Florida’s New Stem Cell Law: What It Signals for Physicians, Patients and the Future of Regenerative Medicine

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and physicians across the country need to be prepared to understand and consider advising patients, where applicable, of these stem cell-related treatment options. The post Florida’s New Stem Cell Law: What It Signals for Physicians,…

Read More

Insurers’ Preliminary Rate Filings Anticipate Biggest Increases in ACA Marketplace Plan Premiums Since 2018

This analysis of preliminary rate filings submitted by 105 ACA Marketplace insurers in 19 states and DC shows that ACA Marketplace insurers are requesting a median premium increase of 15% for 2026, which would represent the largest hike in premiums since 2018, the last time policy uncertainty contributed to sharp premium growth. The scheduled expiration…

Read More

What will be DOGE’s impact on CMS?

In a statement today, CMS confirmed that Elon Musk and the Department of Government Efficiency (DOGE) has been given access to CMS payment systems: CMS has two senior Agency veterans – one focused on policy and one focused on operations – who are leading the collaboration with DOGE, including ensuring appropriate access to CMS systems…

Read More

Should Drug Companies Be Advertising to Consumers?

Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arlington, Virginia, to Warren, Rhode Island, where she knew all of two people. “I was kind of a mess,” recalled Abrams, 69. Trying to cope, “I was eating…

Read More